Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

(603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Addition of Estimated Amount of Routine Related Party Transactions for 2026

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603139 · · 5 pages · Chinese

Summary by 6ix AI

Shaanxi Kanghui Pharmaceutical Co., Ltd. has announced the addition of estimated amounts for routine related party transactions for the upcoming year. The board has approved the proposal after thorough review by independent directors and the audit committee, ensuring that the transactions will not harm the interests of shareholders. The estimated total for these transactions has been increased based on the company's operational needs and market conditions. The announcement details the nature of the transactions and the relationships with the related parties involved.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603139shaanxi-kanghui-pharmaceutical-co-ltdannouncement-on-addition-of-estimated-amount-of-routine-related-party-transactions-for-2026

Release

Announcement on Addition of Estimated Amount of Routine Related Party Transactions for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases